United States

People: Abaxis Inc (ABAX.O)

ABAX.O on Nasdaq

23 Jun 2017
Change (% chg)

$0.81 (+1.57%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Severson, Clinton 

Mr. Clinton H. Severson is Chairman of the Board, Chief Executive Officer of the Company. He was President of Abaxis, Inc. He was appointed Chairman of the Board in May 1998. Since June 2011, Mr. Severson served on the Board of Directors of Response Biomedical Corporation (CDNX: RBM). Since November 2008, Mr. Severson served on the Board of Directors of Trinity Biotech (NASDAQ: TRIB), a biotechnology company. From November 2006 to February 2012, Mr. Severson served on the Board of Directors of CytoCore, Inc. (OTCBB: CYOE.OB), a biotechnology company. From February 1989 to May 1996, Mr. Severson served as President and Chief Executive Officer of MAST Immunosystems, Inc., a privately-held medical diagnostic company. Mr. Severson is also a member of the board of directors of a privately-held company. Mr. Severson was selected as a director because of his in-depth knowledge of our operations, financial condition and strategy in his position as our President and Chief Executive Officer, as well as his extensive senior management experience in medical diagnostics and experience serving on the boards of various public and private companies.

Basic Compensation

Total Annual Compensation, USD 1,318,120
Restricted Stock Awards, USD 3,029,400
Long-Term Incentive Plans, USD --
All Other, USD 13,679
Fiscal Year Total, USD 4,361,190

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Clinton Severson


Donald Wood


Ross Taylor


Kenneth Aron


Craig Tockman


Achim Henkel

As Of  30 Mar 2016